Ophthotech reported $-30201000 in EBITDA for its second fiscal quarter of 2021.


Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
width
height
Ebitda Change
Applied Genetic Technologies AGTC:US $ -15.64M 2.66M
Insmed INSM:US $ -91545000 6.9M
Nektar Therapeutics NKTR:US $ -109.98M 3.32M
Novartis NOVN:VX SF 4837M 65M
Regeneron Pharmaceuticals REGN:US $ 1920.4M 1497.9M